LncRNA LINK-A Remodels Tissue Inflammatory Microenvironments to Promote Obesity.
Yu ChenHui ChenYing WangFangzhou LiuXiao FanChengyu ShiXinwan SuManman TanYebin YangBangxing LinKai LeiLei QuJiecheng YangZhipeng ZhuZengzhuang YuanShanshan XieQinming SunDante NeculaiWei LiuQingfeng YanXiang WangJianzhong ShaoJian LiuAifu LinPublished in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
High-fat diet (HFD)-induced obesity is a crucial risk factor for metabolic syndrome, mainly due to adipose tissue dysfunctions associated with it. However, the underlying mechanism remains unclear. This study has used genetic screening to identify an obesity-associated human lncRNA LINK-A as a critical molecule bridging the metabolic microenvironment and energy expenditure in vivo by establishing the HFD-induced obesity knock-in (KI) mouse model. Mechanistically, HFD LINK-A KI mice induce the infiltration of inflammatory factors, including IL-1β and CXCL16, through the LINK-A/HB-EGF/HIF1α feedback loop axis in a self-amplified manner, thereby promoting the adipose tissue microenvironment remodeling and adaptive thermogenesis disorder, ultimately leading to obesity and insulin resistance. Notably, LINK-A expression is positively correlated with inflammatory factor expression in individuals who are overweight. Of note, targeting LINK-A via nucleic acid drug antisense oligonucleotides (ASO) attenuate HFD-induced obesity and metabolic syndrome, pointing out LINK-A as a valuable and effective therapeutic target for treating HFD-induced obesity. Briefly, the results reveale the roles of lncRNAs (such as LINK-A) in remodeling tissue inflammatory microenvironments to promote HFD-induced obesity.
Keyphrases
- insulin resistance
- high fat diet
- adipose tissue
- metabolic syndrome
- high fat diet induced
- skeletal muscle
- polycystic ovary syndrome
- diabetic rats
- type diabetes
- high glucose
- weight loss
- oxidative stress
- uric acid
- weight gain
- endothelial cells
- drug induced
- nucleic acid
- poor prognosis
- squamous cell carcinoma
- gene expression
- genome wide
- stem cells
- dna methylation
- binding protein
- neoadjuvant chemotherapy
- cardiovascular risk factors
- physical activity